SCHEMBL8733210

SCHEMBL8733210

C[C]c1cccc(OC)c1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.56
CYP3A4 P08684 1/20 0.56
ACHE P22303 1/20 0.52
CA1 P00915 3/20 0.50
CA2 P00918 3/20 0.50
CA9 Q16790 3/20 0.50
GRM5 P41594 3/20 0.50
CA12 O43570 2/20 0.50
CA7 P43166 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.47
CES2 O00748 1/20 0.45
CES1 P23141 1/20 0.45
ENPP2 Q13822 1/20 0.45
CHRM2 P08172 1/20 0.45
CHRM1 P11229 1/20 0.45
CHRM3 P20309 1/20 0.45
CA4 P22748 1/20 0.44
FFAR1 O14842 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6132140 0.84 GRM5 (0.66) ALDH1A1CYP3A4ACHECA1CA2
SCHEMBL30707880 0.84 GRM5 (0.66) ALDH1A1CYP3A4ACHECA1CA2
SCHEMBL7601866 0.83 GRM5 (0.56) ALDH1A1CYP3A4ACHECA1CA2
SCHEMBL29994376 0.83 GRM5 (0.56) ALDH1A1CYP3A4ACHECA1CA2
SCHEMBL852785 0.80 ACHE (0.50) ALDH1A1CYP3A4ACHECA1CA2
SCHEMBL182676 0.80 ACHE (0.50) ALDH1A1CYP3A4ACHECA1CA2
SCHEMBL30083320 0.80 P4HB (0.55) ALDH1A1CYP3A4ACHECA1CA2
SCHEMBL103841 0.80 P4HB (0.55) ALDH1A1CYP3A4ACHECA1CA2
SCHEMBL96045 0.80 CA1 (0.53) ALDH1A1CYP3A4ACHECA1CA2
SCHEMBL29666208 0.80 ACHE (0.50) ALDH1A1CYP3A4ACHECA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998043649-A2 AGE PRODUCTION INHIBITORY COMPOSITION COMPRISING A MAILLARD REACTION INHIBITOR AND VITAMIN B¿6? OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1998-10-08 WO disclosed
US-5422360-A Hydrazonoimidazolidin-4-one derivatives; treatment of diabetes and aging disorders OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-06-06 US disclosed
EP-0531812-A1 Maillard reaction inhibitor, process for producing it, composition containing it and the use thereof OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-03-17 EP disclosed